newsfilter
← Latest News
PR Newswire·

Inhibrx Reports Third Quarter 2025 Financial Results

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the third quarter of 2025. Following the...